RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 68 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,884,000 | -87.6% | 2,214,200 | -19.5% | 0.00% | -100.0% |
| Q1 2022 | $15,158,000 | -43.1% | 2,751,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $26,630,000 | -43.8% | 2,751,000 | +3.8% | 0.00% | -50.0% |
| Q3 2021 | $47,400,000 | +33.9% | 2,651,000 | +82.8% | 0.01% | +33.3% |
| Q2 2021 | $35,403,000 | -7.9% | 1,450,333 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $38,434,000 | +353.3% | 1,450,333 | +29.8% | 0.01% | +250.0% |
| Q4 2020 | $8,478,000 | +51.5% | 1,117,000 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $5,596,000 | -16.2% | 1,117,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $6,680,000 | -14.8% | 1,117,000 | -36.6% | 0.00% | 0.0% |
| Q1 2020 | $7,844,000 | -84.1% | 1,762,598 | -66.0% | 0.00% | -81.8% |
| Q4 2019 | $49,182,000 | +104.6% | 5,177,000 | +69.1% | 0.01% | +83.3% |
| Q3 2019 | $24,040,000 | -50.1% | 3,062,396 | 0.0% | 0.01% | -45.5% |
| Q2 2019 | $48,171,000 | -13.1% | 3,062,396 | 0.0% | 0.01% | -15.4% |
| Q1 2019 | $55,429,000 | +15.1% | 3,062,396 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $48,149,000 | -29.1% | 3,062,396 | +5.9% | 0.01% | -23.5% |
| Q3 2018 | $67,869,000 | – | 2,892,396 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |